Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2)

Summary

The goal of this monocentric interventional study is to evaluate the efficacy, in terms of objective response rate, of the 188Re-SSS lipiodol SIRT in patients with non-operable HCC.

Timeline

Start

2024-02-14

Primary completion

2025-01-13

Completion

2026-04-24

Outcome

Outcome not reported

Stopped: “The last visit of the last patient was done.”

Drugs

Indications